Zobrazeno 1 - 10
of 85
pro vyhledávání: '"José Juan Pereyra"'
Autor:
Ricardo Ruiz-Villaverde, Marta Cebolla-Verdugo, Alvaro Prados-Carmona, José Juan Pereyra Rodríguez, José Carlos Armario-Hita
Publikováno v:
Life, Vol 14, Iss 10, p 1236 (2024)
Dermatology is one of the oldest specialties and yet one of the most innovative and constantly evolving ones, too [...]
Externí odkaz:
https://doaj.org/article/b397f995e5f047de86e163f5d49fea74
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antonio Alcalá Ramírez del Puerto, Juan Carlos Hernández‐Rodriguez, Mercedes Sendín‐Martín, Juan Ortiz‐Alvarez, Julián Conejo‐Mir Sánchez, José Juan Pereyra‐Rodriguez
Publikováno v:
International Journal of Dermatology. 62:776-782
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ca6605d7fa97671b51cd046e27bdbfc
https://doi.org/10.1111/ijd.16618
https://doi.org/10.1111/ijd.16618
Autor:
Francisco Navarro-Triviño, Sara Alcantara-Luna, Javier Domínguez-Cruz, Manuel Galán-Gutiérrez, Ricardo Ruiz-Villaverde, José-Juan Pereyra-Rodriguez, José-Carlos Armario-Hita
Publikováno v:
Immunotherapy.
Atopic dermatitis is an inflammatory skin disease, the prevalence of which has increased in the last decade. It affects all age groups, with adult involvement being a major focus of interest in recent years. The unmet needs of the disease, such as pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c41a761d7ac5e81f64ce0f5f83592d8
https://doi.org/10.2217/imt-2023-0037
https://doi.org/10.2217/imt-2023-0037
Autor:
José-Juan Pereyra-Rodríguez, Pedro Herranz, Ricardo Ruiz-Villaverde, Marta Elosua-González, Manuel Galán-Gutiérrez, Ignasi Figueras-Nart, Javier Miquel, Pablo de la Cueva, Esther Serra-Baldrich, Monica Munera-Campos, Gemma Melé-Ninot, Vicente Expósito-Serrano, Bibiana Perez, Amalia Serrano, Javier F Ortiz de Frutos, José C Armario-Hita
Publikováno v:
Clinical and Experimental Dermatology.
Background Tralokinumab was recently approved for the treatment of moderate-to-severe atopic dermatitis (AD) and is the first selective interleukin (IL)-13 inhibitor that specifically neutralizes IL-13 with high affinity. Objectives To determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a588f39220d31984807e6ed0b3da363
https://doi.org/10.1093/ced/llad153
https://doi.org/10.1093/ced/llad153
Autor:
Antonio José Durán-Romero, Mercedes Sendín-Martín, Julián Conejo-Mir, P. Martín-Carrasco, José Juan Pereyra-Rodríguez
Publikováno v:
European Journal of Dermatology. 31:486-492
Non-melanoma skin cancers (NMSCs) are the most frequent group of malignant tumours worldwide. Objectives: The aim of the present research was to analyse mortality associated with NMSC in Spain between 1979 and 2018 and highlight changes regarding tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41478fdd35e1339efe7bf326730cbd9f
https://doi.org/10.1684/ejd.2021.4110
https://doi.org/10.1684/ejd.2021.4110
Autor:
Angela Ayen-Rodríguez, José-Juan Pereyra-Rodríguez, Francisco J. Navarro-Triviño, Sara Alcantara-Luna, Javier Domínguez-Cruz, Manuel Galán-Gutiérrez, Samuel Vilar-Palomo, Jose Carlos Armario-Hita, Ricardo Ruiz-Villaverde
Introduction: Atopic dermatitis (AD) is a genetically based chronic inflammatory dermatosis associated with multiple triggers and complex pathophysiological mechanisms. Nowadays, an authentic therapeutic revolution is taking place with the incorporat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d524a3aa5a865dc9b7c6c496f11334f6
https://hdl.handle.net/10668/21401
https://hdl.handle.net/10668/21401
Autor:
Juan-Carlos Hernández-Rodríguez, Mercedes Sendín-Martín, Antonio-José Durán-Romero, Juan Ortiz Álvarez, Julián Conejo-Mir, José-Juan Pereyra-Rodríguez
Publikováno v:
Clinical and experimental dermatologyReferences. 47(11)
Background Systemic sclerosis (SSc) is an autoimmune chronic rheumatic disease with a high mortality rate, which continues to be a challenge for clinicians today. Aim To assess changes in mortality trends in the Spanish SSc population between 1980 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::662d2b8186dfe274f8193ec8266712ce
https://pubmed.ncbi.nlm.nih.gov/35875897
https://pubmed.ncbi.nlm.nih.gov/35875897
Publikováno v:
International Journal of Dermatology. 60:844-850
Background Melanoma mortality rates are stabilizing and in certain regions and age groups are trending down. Although there are some studies that predict melanoma mortality in other countries, there are currently no studies that predict mortality in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba2326cc89b7ba95b4105eb0aed3eb8
https://doi.org/10.1111/ijd.15438
https://doi.org/10.1111/ijd.15438
Autor:
Juan‐Carlos Hernández‐Rodríguez, Guiovana‐Fernanda Osorio‐Gómez, Juan Ortiz‐Álvarez, José‐Antonio Lebrón‐Martín, Julián Conejo‐Mir, José‐Juan Pereyra‐Rodríguez
Publikováno v:
Australasian Journal of Dermatology. 63
Down syndrome (DS) has been related to a higher risk of hidradenitis suppurativa (HS). This cross-sectional study assessed DS patients with HS in a Spanish single-centre sample. DS participants presented a lower age of onset, age at diagnosis and tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d96a503435cc89cecd0117c22bed4fa
https://doi.org/10.1111/ajd.13872
https://doi.org/10.1111/ajd.13872